If you read the announcements, the efficacy as a combination was shown in pre-clinical studies.
Ph1 human studies are done to ensure that the drug (in this case IHL-675A) is tolerated and has no additional unknown side effects (due to the combination of two drugs in this case).
Ann: Ethics Approval Received to start Ph 1 Clinical of IHL 675A, page-12
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)